Bank of New York Mellon Corp Reduces Stake in Omega Healthcare Investors, Inc. $OHI

Bank of New York Mellon Corp cut its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 4,293,812 shares of the real estate investment trust’s stock after selling 164,163 shares during the period. Bank of New York Mellon Corp’s holdings in Omega Healthcare Investors were worth $188,155,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in shares of Omega Healthcare Investors during the 4th quarter valued at about $156,166,000. Invesco Ltd. increased its position in Omega Healthcare Investors by 101.7% during the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock worth $208,775,000 after purchasing an additional 2,493,877 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Omega Healthcare Investors during the fourth quarter worth about $93,476,000. Cbre Investment Management Listed Real Assets LLC increased its position in Omega Healthcare Investors by 327.5% during the fourth quarter. Cbre Investment Management Listed Real Assets LLC now owns 2,222,799 shares of the real estate investment trust’s stock worth $98,559,000 after purchasing an additional 1,702,846 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its stake in Omega Healthcare Investors by 84.6% during the third quarter. Daiwa Securities Group Inc. now owns 3,058,031 shares of the real estate investment trust’s stock worth $129,110,000 after purchasing an additional 1,401,066 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $50.16 on Friday. The firm’s 50 day moving average price is $47.17 and its 200-day moving average price is $46.22. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. Omega Healthcare Investors, Inc. has a one year low of $37.70 and a one year high of $50.75. The firm has a market cap of $14.94 billion, a P/E ratio of 24.23, a P/E/G ratio of 2.14 and a beta of 0.58.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The company had revenue of $322.95 million for the quarter, compared to analysts’ expectations of $264.07 million. During the same period in the previous year, the business posted $0.75 EPS. The business’s revenue for the quarter was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, equities research analysts predict that Omega Healthcare Investors, Inc. will post 3.09 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 5.3%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 129.47%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. UBS Group set a $47.00 target price on shares of Omega Healthcare Investors in a report on Thursday, June 18th. Scotiabank cut their price target on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Bank of America reaffirmed an “underperform” rating and set a $46.00 price target (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. Barclays initiated coverage on Omega Healthcare Investors in a report on Tuesday, July 7th. They issued an “underweight” rating and a $51.00 price objective on the stock. Finally, Citigroup reiterated a “market perform” rating on shares of Omega Healthcare Investors in a research report on Monday, June 15th. Five research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus target price of $48.50.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.